Form 4: Zimmer Biomet Director Betsy J. Bernard Reports Acquisition of Phantom Stock Units and Restricted Stock Units

Director Betsy J. Bernard reports acquisition of phantom stock units and restricted stock units in Zimmer Biomet Holdings, Inc.

Summary

• On May 10, 2024, Betsy J. Bernard, a director of Zimmer Biomet Holdings, Inc., reported the acquisition of 616.726 phantom stock units and 1,068.991 restricted stock units.
• The phantom stock units were accrued under the company's Deferred Compensation Plan for Non-Employee Directors at a price of $121.61 per unit.
• These units will be settled in shares of company common stock within sixty days after cessation of service as a director.
• The restricted stock units are immediately 100% vested but subject to mandatory deferral until the later of termination of service as a director or three years after the grant date.
• Following the reported transactions, Bernard beneficially owns 19,501.129 phantom stock units and 21,577.928 restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock unit acquisitions by a director, indicating alignment with the company's performance but not necessarily a strong positive or negative signal.

Positives

• The acquisition of stock units by a director can be seen as a positive sign, indicating confidence in the company's future performance.
• The vesting and deferral terms of the restricted stock units align the director's interests with the long-term success of the company.

Future Outlook

The phantom stock units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Industry Context

This filing is a routine disclosure of stock ownership changes by a company insider, which is common in publicly traded companies. It provides transparency to investors regarding the alignment of interests between management and shareholders.

Comparison to Industry Standards

• Stock-based compensation is a common practice among publicly traded companies, especially in the healthcare and medical device industries.
• Companies like Stryker, Johnson & Johnson, and Medtronic also utilize stock options, restricted stock units, and performance-based equity awards to incentivize their executives and directors.
• The specific terms of these awards, such as vesting schedules and deferral periods, can vary widely based on company-specific factors and industry norms.

Stakeholder Impact

• The acquisition of stock units by a director can positively influence shareholder confidence.
• The vesting and deferral terms of the restricted stock units align the director's interests with the long-term success of the company, which benefits shareholders.

Key Dates